Prevalence and Prognostic Value of Lymph Node Dissection in Treating Adrenocortical Carcinoma: A National Experience.
We examined a national database to investigate the role of lymph node dissection (LND) in adrenocortical carcinoma (ACC) treated surgically. Patient data diagnosed with ACC between 1991 and 2011 were extracted from a national database. Predictors of LND, positive lymph nodes on LND, and the association between positive LND and cancer-specific death were examined. Only 5.39% of patients underwent LND, and 31.03% had positive lymph nodes. Disease stage was the only significant predictor of LND (odds ratio=3.061; 95% confidence interval=1.158-8.091), and finding more than one positive lymph nodes on LND was the only significant predictor of cancer-specific death (hazard ratio=3.13; 95% confidence interval=1.233-7.95) in tumors larger than 3 cm in size. LND is not a common practice in treating ACC in the United States. The finding of more than one positive lymph nodes on LND for ACC is associated with poor prognosis.